
Genitourinary Cancer Research Team @CityofHope
1.1K posts

Genitourinary Cancer Research Team @CityofHope
@CityofHope_GU
Patient-Focused Care | Clinical Trials | Research | Cures @CityofHope #GenitourinaryCancers #GU #Prostate #Kidney #Bladder #Testis #CityofHope #GuResearchTeam🔬











Congratulations @SalvadorjcMD!! Hope you brought an extra suitcase for all your awards. Making the @CityofHope @MontyPal team proud at #KCRS24

Please join me in congratulating @shilpaonc who is promoted to Professor of Medicine @CleClinicLCM @cwru @CleClinicMD @ClevelandClinic !!





City of Hope ranked Top 5 in the nation for cancer care by U.S. News & World Report! Learn more: bit.ly/3LqJshK #BestHospitals

Very proud of this #ClinicalTrial of Cabozantinib/Nivolumab #CaboNivo & Cabozantinib/ Nivolumab/Ipilimumab #CaboNivoIpi published @JCO_ASCO, that includes #rareGUtumors & took years to complete but laid the foundation for many future trials in oncology gcc02.safelinks.protection.outlook.com/?url=https%3A%…


Watch first author Sumanta K. Pal (@montypal) discuss his research article, CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell #Carcinoma, published simultaneously at #AACR24: vimeo.com/932606570/8875… @cityofhope








Congratulations to Alexis LeVee, MD, for receiving the Cary Presant, MD Young Investigator Award at The @MOASC_Office , Inc. 9th Annual Oncology Summit & Research Symposium. Dr. LeVee, Chief Fellow, Hematology & Medical Oncology at City of Hope National Medical Center, was recognized for her research exploring how certain bacteria in the intestine of breast cancer patients with HER2+ disease may enhance the effectiveness of immunologic and gene-targeted therapies. The award was supported by a research grant from @AVEOOncology , an LG Chem company. We applaud Dr. LeVee for her innovative work that has the potential to improve cancer patients’ lives. #pharma #cancerresearch #oncology #MOASC



Just in 👉data from @SWOG 1216 trial in mHSPC#prostatecancer👉 PSA level at 3 and 7 months after starting ADT Rx are strongly prognostic of OS: It’s time to design de- or escalation trials based on response biomarkers. OPEN access👉 tinyurl.com/3azhpt4r @OncoAlert @urotoday
















Spent Saturday night at the @franksstillhere gala raising money for (and celebrating!) the brilliant, kind and inspiring @montypal. So lucky to work with him and many other awesome docs like @cmhugen at @cityofhopeoc. (And was joined by amazing friends too!) Best night!